DJIA 17,079.57 -42.44 -0.25%
NASDAQ 4,557.70 -11.93 -0.26%
S&P 500 1,996.74 -3.38 -0.17%
market minute promo

50.54 0.29 (0.58%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

BMY $50.54 0.58%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $50.16
Previous Close $50.25
Daily Range $50.16 - $50.65
52-Week Range $41.32 - $57.49
Market Cap $83.8B
P/E Ratio 31.21
Dividend (Yield) $1.44 (2.9%)
Ex-Dividend Date
Dividend Pay Date
Volume 3,436,344
Average Daily Volume 5,911,518
Current FY EPS $1.77





Bristol-Myers Squibb Co. (BMY) Description

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments. Website:

News & Commentary

Has Gilead Sciences, Inc.'s Star Drug Already Peaked?

Prescriptions of Gilead Sciences' hepatitis C drug Sovaldi peaked, but sales will pick up after the new combination product is approved.

Bristol-Myers' Oral HCV Treatment Daklinza Gets EU Clearance - Analyst Blog

Bristol-Myers Squibb's Daklinza Threatens Johnson & Johnson More Than Gilead Sciences

European approval of Bristol-Myers Squibb's Daklinza could derail sales of Johnson & Johnson's Olysio, but is unlikely to unseat Gilead's Sovaldi.

Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers at Hold

Will This Coverage Initiation Affect Bristol-Myers Squibb (BMY) Stock Today?

3 Reasons Pfizer Inc.'s Stock Could Fall

Despite rumors about mergers and acquisitions, these three catalysts could wind up pressuring Pfizer's stock and ultimately pushing it lower.

Analysts' Actions: Akamai, Bristol-Myers, Eli Lilly, Merck, Pfizer

US Stock Futures Edge Higher Ahead Of Tiffany Earnings

With An Iffy Non-Oncology Pipeline, Roche Pays Up For InterMune

4 Foreign Blue-Chip Stocks With 4% Dividend Yields to Buy

See More BMY News...

BMY's Top Competitors

BMY $50.54 (0.58%)
Current stock: BMY
JNJ $102.95 (-0.26%)
Current stock: JNJ
NVS $89.73 (-0.30%)
Current stock: NVS
RHHBY $36.56 (-0.19%)
Current stock: RHHBY